4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-003002
Director sold 6,450 shares at $8.75 ($56,454)
From the SEC's structured data for this filing
Trades in this filing
Sinha Vikas · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-20 | Sale : show line 1 in the form | −6,450 | $8.75 | $56,454 | 858,957 | D |
| Open-market sales · 6,450 sh · avg $8.75 · $56,454 | ||||||
Loading xslF345X03/doc4.xml…